TruthArchive.ai - Related Video Feed

I frequently visit Africa and witness the impact of failing crops, leading to malnutrition and vulnerability to diseases. However, progress has been made since 2000, with child deaths due to malaria, diarrhea, and pneumonia decreasing from over 10 million to below 5 million in 2019, thanks to generous funding and initiatives like the vaccine fund. Despite challenges such as climate change and the pandemic, we aim to further reduce deaths by half by 2030. Human development is crucial, and focusing solely on climate without addressing healthcare would be detrimental. Africa faces significant challenges, and collaboration with France is essential in developing the best strategy for the continent.

This is a challenging time, and all progress is at risk due to tight budgets and tough trade-offs. Aid is down by $30 billion this year alone. Cuts in health resources, combined with the financial situation in low-income countries, will cause setbacks. Without available vaccines, babies will not survive, and measles epidemics will continue due to fewer resources for primary health care. The life of a child could have been saved by a vaccine that costs just 30¢. Trend lines will briefly go into reverse. It is unknown if progress will resume in two, four, or six years. With the return of resources and the advantage of an incredible pipeline of innovation, new drugs, and new vaccines, progress will resume.

We commit to bringing new medicines to the US, Europe, and the world every year. These medicines will be added to our portfolio for these countries. This fulfills a dream we had when we started in 2019. In that year, we set goals for the next five years, including reducing the global population by 50% by 2023. Today, this dream is becoming a reality, making us a purpose-driven company.

We commit to bringing new medicines to the US, Europe, and the world every year. These medicines will be added to our portfolio. This fulfills a dream we had in 2019 when we set goals for the next five years. One of those goals was to reduce the world's population by 50% by 2023. Today, this dream is becoming a reality. We are a purpose-driven company.

Speaker 0: Prime minister Shigeru Ishba, Gates highlighted the importance of upcoming high level talks in Japan focused on advancing health care in Africa. He emphasized how Japanese innovation could lead the new health products benefiting Africa. Global health, activities with Gobi, with Global Fund, and the kind of innovation taking place in Japan that'll, create new products that

The goal is to achieve a 5% to 7% return by distributing vaccines effectively. Ensuring proper usage and logistics is crucial, along with obtaining necessary licenses. The Gates Foundation will absorb the first 20% of losses and share 50% of any additional losses, aiming for no losses for investors. The fund is designed to last around 10 years, focusing on preventing wasted investments in philanthropy. With the expertise of the Gates Foundation, this initiative could pave the way for future projects beyond just drugs and vaccines, potentially leading to a sustainable model for intelligent investment in impactful health initiatives.

A French scientist in South Africa proved that promoting circumcision services in a township called Orange Farm resulted in over 80% coverage among young men aged 12 to 20. To reduce the need for extensive surgical time, a device called the Shang ring was invented, which allows the procedure to be completed in just a few minutes instead of the usual 30 minutes. While this is not a substitute for a vaccine, it is a cost-effective solution for heavily affected areas. By investing approximately $1 billion, we can promote, roll out, and deliver these circumcisions using the Shang ring, which simplifies the training required and the complexity of the procedure.

The speaker states that organizations like the Gates Foundation are recommitting to global health initiatives. Despite challenges, there is optimism regarding the potential eradication of diseases like polio and malaria within the next twenty years, citing available tools and strategies. The Gates Foundation is pledging $1.6 billion to Gavi for the next five years and will invest billions more in developing new, low-cost vaccines to enhance Gavi's effectiveness. The speaker quotes Nelson Mandela on the importance of how a society treats its children, noting that Gavi has helped over one billion children live healthier lives in the last 25 years. Continued support is crucial to maintain this progress in the coming decades.

In this video, the speaker discusses their ambitious goals for the next 10 to 15 years in tackling various diseases. They believe that over half of the 20 diseases targeted by their global program can see a significant impact within this timeframe. While some diseases like AIDS may not see a dramatic improvement, others like malaria have potential solutions in the pipeline. The speaker emphasizes the importance of reducing mortality rates in developing countries, as it positively affects population growth, education, and nutrition. They use dashboards internally to track progress and share results transparently. The speaker also mentions the value of learning from any shortcomings and lessons that can be applied to other foundations.

Creating mRNA is easy, cheap, and scalable. In the next 5 years, we aim to improve stability and cost, allowing for global vaccine production. mRNA will be explored for diseases like HIV, malaria, and TB with various approaches. The Gates Foundation and other global health organizations will support mRNA vaccine development.

We ensure there is enough capacity and competition for vaccines, leading to lower prices and the development of new vaccines. This includes vaccines for TB, malaria, HIV, and even COVID-19. To improve vaccines, we aim for longer duration and broader coverage, and plan to replace needles with patches. The pandemic has shown that we have not invested enough in these innovations. Our partners in India play a crucial role in achieving these breakthrough products.

We should not return to our complacency about pandemics. In the future, we can have mega testing platforms that are quick, inexpensive, and can test 20% of the population weekly. Monoclonal antibodies show promise in reducing death rates by 80%. The mRNA platform will make vaccine development faster, easier, and cheaper. To prevent future pandemics, we need a global alert system to detect disease outbreaks worldwide. We also need a group of infectious disease responders, like pandemic firefighters, who can quickly build capacity and respond to new pathogens. This investment is like the best insurance policy the world could buy.

We should not return to our complacency about pandemics. In the future, we can have mega testing platforms that are quick, inexpensive, and can test 20% of the population weekly. Monoclonal antibodies are a promising treatment that can reduce death rates by 80%. The development of new vaccines will be faster, easier, and cheaper thanks to the mRNA platform. To prevent future pandemics, we need a global alert system and a group of infectious disease responders who can act quickly. This investment is like the best insurance policy the world could buy.

Over the past 20 years, $10 billion has been invested in vaccinations, resulting in a remarkable return on investment of 20 to 1. This economic benefit far surpasses other options, such as investing in the S&P 500, which would have yielded around $17 billion with reinvested dividends. However, the impact of vaccinations is estimated to be even greater, potentially reaching $200 billion.

For example, there's more money put into baldness drugs than are put into malaria. Now baldness is it's terrible thing. And rich men are afflicted. And so that's why that priority has been set. But malaria, even the million deaths a year caused by malaria, greatly understate its impact. Over two hundred million people at any one time are suffering from it. It means that you can't get the economies in these areas going because there's just it holds things back so much. Malaria is, of course, transmitted by mosquitoes. I brought some here so you could experience this. We'll let those roam around the auditorium a little bit there. There's no reason only poor people should have have the experience. Those mosquitoes are not not infect

In the next 5 years, we can easily and inexpensively produce mRNA, which is the key to its success. We just need to work on improving the stability, cost, and scalability of lipid nanoparticles. Once we achieve that, we can establish factories worldwide to manufacture affordable vaccines within a short time frame. We plan to use mRNA technology for diseases like HIV, malaria, and tuberculosis, with different approaches for each. The Gates Foundation and other organizations focused on global health will support our efforts to develop these missing vaccines using mRNA.

Due to budget constraints and a $30 billion cut in global health aid this year, progress is at risk and low-income countries will experience setbacks. Without sufficient resources for primary healthcare systems and vaccines, easily preventable diseases will continue to cause fatalities. The speaker highlighted the impact of resource cuts, emphasizing that a $0.30 vaccine could save a child's life. Although trend lines will reverse, the speaker believes that progress will resume with restored resources and innovations in drugs and vaccines. The timeline for recovery is uncertain, but the speaker is confident that advancements will continue.

With cooperation, generosity, and innovation, a partnership with BioNTech aims to create vaccines for TB, HIV, and malaria. If the right actions are taken over the next 20 years, most countries can escape the poverty trap and become self-sufficient. Accelerating this process is a positive goal that many leaders are engaged in. However, due to cuts in aid budgets, including Germany's, approximately 30% less funding will be raised for vaccines compared to five years ago.

“And we will have new vaccines. We'll have a, TB vaccine, malaria vaccine, HIV vaccine, and even the things like COVID vaccines.” The speaker envisions vaccines for TB, malaria, HIV, and COVID, with longer duration and broader coverage. “We need to make them have longer duration, more coverage, and we're gonna change instead of using the needle to use a little patch.” The plan includes longer-lasting protection and a switch from needle injections to patch delivery. “So the pandemic really highlighted that we've been underinvested in those innovations, and, you know, our partners in India are are part of how we're gonna get these breakthrough products done.” The pandemic is cited as underscoring underinvestment, with India-based partners playing a role in bringing breakthrough products to fruition.

The Bill and Melinda Gates Foundation has played a significant role in various global health initiatives. They sponsored the creation of Gavi, the Vaccine Alliance, which aims to establish healthy markets for vaccines. The foundation provided substantial funding to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, as well as supported efforts to eliminate neglected tropical diseases. They were also a founding partner of the Global Financing Facility for women, children, and adolescents, contributing $275 million. Additionally, the Gates Foundation injected $100 million into the Coalition For Epidemic Preparedness Innovations to develop vaccines for emerging infectious diseases. Their influence can be seen in numerous major global health initiatives over the past two decades.

The transcript discusses a narrative that connects Bill Gates, Jeffrey Epstein, and a global, pre-planned approach to pandemics, presenting a sequence of alleged events and structures designed to profit from health crises. It begins with a claim that new vaccines and health services could be improved and costs reduced by ten to fifteen percent over the next five to ten years, and that a future pandemic will occur regardless of current efforts. It is stated that the pandemic risk is two to three percent per year and that attention to preparedness will continue, noting that the pandemic was predictable and could be far more severe in the future. One speaker asserts they had predicted the risk of a pandemic and that it came true. The brand-new Epstein files are then introduced, claiming they show Epstein planned the whole thing from the start and expose a financial system designed around pandemics that operated long before COVID-19. The documents allegedly reveal a hidden network directly connecting Bill Gates, Jeffrey Epstein, and other powerful individuals. Epstein is said to have helped design the financial apparatus that later secured over 100 million dollars in funding for the Gates Foundation, advising JPMorgan executives on pitching a Gates Anchored Donor Fund to attract vaccine investments under the guise of philanthropy but designed to generate profits. It is claimed Gates had already invested in vaccines from the early 2000s but faced controversy over mass vaccine distribution and promises of disease eradication, which allegedly sometimes worsened problems. Gates is also quoted as saying vaccines could reduce the global population by a significant amount. There is a point-by-point timeline: the world’s population is described as 6.8 billion, headed toward about 9 billion, with a suggestion that great work on vaccines and reproductive health could lower that by ten to fifteen percent. In 2013, the Gates Foundation allegedly created the Global Health Investment Fund, allowing private investors to fund drug and vaccine development with a stated health purpose, while offering a 60% guarantee of principal, meaning investors would risk only 40% while the remaining 60% of potential losses would be covered by philanthropic and public money. This structure is said to convert global health issues into profitable opportunities with low risk, securing funds and enabling subsequent actions. Epstein’s role is described as expanding Gates’ influence in pandemic preparedness. The 2011 funding groundwork allegedly paved the way for broader governance, with Gates Foundation discussions in 2015 about pandemics and global responses, involving groups like the International Peace Institute, World Health Organization, World Bank, MSF, and UN officials. It is claimed Epstein acted as a back-channel intermediary to spread Gates’ influence, maintaining contacts even after funding refusals, by forwarding Gates’ articles on pandemic preparedness. The timeline continues with 2017 being a turning point, where pandemics were discussed as business opportunities rather than disasters, and Epstein was said to broker specialists into Gates’ office for pandemic simulations. A doctor’s text is cited indicating pandemic simulation as a key credential, with Epstein recommending a connection to Gates. That year also saw the World Bank launch the first emergency financing facility, raising $320 million in bonds named to cover coronavirus risks, implying planning for a coronavirus-style outbreak years in advance. In October 2019, six weeks before COVID-19, Event 201—a pandemic simulation modeled on a novel coronavirus—was co-hosted by the Johns Hopkins Center for Health Security, the World Economic Forum, and the Gates Foundation, focusing on government policy during a viral outbreak, distribution of drugs, media messaging, social media management, public compliance, and unified global response. Six weeks later, the real outbreak began. While the documents are not proof, and other evidence such as patents and gain-of-function funding are cited, the narrative suggests a pattern of pre-planned preparation, money, simulations, networks, vaccines, and elite alignment. The closing question asks readers to consider who benefits when such world-stage events occur, proposing that identifying beneficiaries clarifies the situation.

New vaccines for tuberculosis, malaria, HIV, and COVID-19 are being developed. These vaccines aim to have longer-lasting effects and wider coverage. In addition, instead of using needles, a patch will be used for administration. The COVID-19 pandemic has brought attention to the fact that we have not invested enough in these innovative advancements.